The role of the mast cell in asthma: a reassessment

Purpose of reviewInterest in the role of the mast cell in bronchial asthma has waxed and waned over several decades, but there is now compelling evidence that mast cells make an important contribution to the pathophysiology of this disease. This review will discuss current advances in this field. Recent findingsMast cells, but not T cells or eosinophils, localize within the bronchial smooth muscle bundles in patients with asthma but not in normal individuals or those with eosinophilic bronchitis. Smooth muscle mast cell density correlates significantly with indices of bronchial hyperresponsiveness, and is likely to be an important factor determining the asthmatic phenotype. Tryptase induces proliferation in human airway smooth muscle, and the recently identified transmembrane form induces the development of bronchial hyperresponsiveness in mice. IL-4 and IL-13, known mast cell products, also induce bronchial hyperresponsiveness in the mouse, in the absence of an inflammatory response. There are therefore several pathways by which the close approximation of mast cells with airway smooth muscle cells might lead to disordered smooth muscle function. Mast cells also infiltrate the airway mucous glands in patients with asthma, showing features of degranulation, and a positive correlate with the amount of mucus obstructing the airway lumen. Taken together these observations suggest that mast cells also play an important role in regulating mucous gland secretion. SummaryThe development of potent and specific inhibitors of mast cell secretion, which remain active when administered long term to asthmatic airways, should offer a novel approach to the treatment of asthma.

[1]  P. Foster,et al.  Biochemical and Functional Characterization of Human Transmembrane Tryptase (TMT)/Tryptase γ , 2002, The Journal of Biological Chemistry.

[2]  A. James,et al.  Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma , 2002, Thorax.

[3]  J. Rosenbloom,et al.  Mast Cell Chymase Modifies Cell-Matrix Interactions and Inhibits Mitogen-Induced Proliferation of Human Airway Smooth Muscle Cells1 , 2002, The Journal of Immunology.

[4]  I. Pavord,et al.  Mast-cell infiltration of airway smooth muscle in asthma. , 2002, The New England journal of medicine.

[5]  M. Grunstein,et al.  IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[6]  I. Hall,et al.  Tryptase's potent mitogenic effects in human airway smooth muscle cells are via nonproteolytic actions. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[7]  D. Cooper,et al.  Ultrastructure of airways in children with asthma , 1978, Histopathology.

[8]  H. Young,et al.  Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. , 2001, The Journal of clinical investigation.

[9]  R. Marthan,et al.  Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. , 2001, Journal of applied physiology.

[10]  H. Sampson,et al.  Fatalities due to anaphylactic reactions to foods. , 2001, The Journal of allergy and clinical immunology.

[11]  D. Cockcroft,et al.  Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. , 2000, The Journal of allergy and clinical immunology.

[12]  Cecilia Kim,et al.  Altered expression and action of the low-affinity IgE receptor FcϵRII (CD23) in asthmatic airway smooth muscle , 1999 .

[13]  A J Wardlaw,et al.  Eosinophilic bronchitis is an important cause of chronic cough. , 1999, American journal of respiratory and critical care medicine.

[14]  P. Howarth,et al.  The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. , 1999, The European respiratory journal.

[15]  S. Durham,et al.  Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. , 1997, Journal of immunology.

[16]  R. Pawankar,et al.  Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. , 1997, The Journal of clinical investigation.

[17]  A. Ammit,et al.  Mast cell tryptase potentiates histamine-induced contraction in human sensitized bronchus. , 1997, The European respiratory journal.

[18]  B. Helm,et al.  Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitization with antigen‐specific IgE , 1996, European journal of immunology.

[19]  P. Paggiaro,et al.  Tolerance to the protective effect of salmeterol on allergen challenge. , 1996, Chest.

[20]  J. Butterfield,et al.  Human lung mast cell activation leads to IL-13 mRNA expression and protein release. , 1996, American journal of respiratory cell and molecular biology.

[21]  C. Tkaczyk,et al.  Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes , 1996, European journal of immunology.

[22]  R. Tanaka,et al.  Inhaled tryptase causes bronchoconstriction in sheep via histamine release. , 1996, American journal of respiratory and critical care medicine.

[23]  P. Bradding.  Human mast cell cytokines , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[24]  M. Gelb,et al.  A link between catalytic activity, IgE-independent mast cell activation, and allergenicity of bee venom phospholipase A2. , 1995, Journal of immunology.

[25]  S. Ruoss,et al.  Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cells. , 1995, American journal of respiratory cell and molecular biology.

[26]  J. Guillet,et al.  Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma. , 1995, Cellular immunology.

[27]  L. Hültner,et al.  Co-activation of naive CD4+ T cells and bone marrow-derived mast cells results in the development of Th2 cells. , 1995, International immunology.

[28]  S. Jewell,et al.  Rat peritoneal mast cells present antigen to a PPD-specific T cell line. , 1994, Cellular immunology.

[29]  P. Howarth,et al.  Interleukin 4 is localized to and released by human mast cells , 1992, The Journal of experimental medicine.

[30]  D. Broide,et al.  Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. , 1991, The Journal of allergy and clinical immunology.

[31]  V. Casolaro,et al.  Human basophil/mast cell releasability. V. Functional comparisons of cells obtained from peripheral blood, lung parenchyma, and bronchoalveolar lavage in asthmatics. , 1989, The American review of respiratory disease.

[32]  S. Holgate,et al.  Cellular events in the bronchi in mild asthma and after bronchial provocation. , 1989, The American review of respiratory disease.

[33]  J. Nadel,et al.  Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs. , 1989, The Journal of clinical investigation.

[34]  S. Wenzel,et al.  Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma. , 1988, The American review of respiratory disease.

[35]  A. Wardlaw,et al.  Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. , 1988, The American review of respiratory disease.

[36]  T. Casale,et al.  Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness. , 1987, The Journal of clinical investigation.

[37]  M. Church,et al.  Inhibition of IgE‐dependent histamine release from human dispersed lung mast cells by anti‐allergic drugs and salbutamol , 1987, British journal of pharmacology.

[38]  N. Johnson,et al.  Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction. , 1985, British medical journal.